Novo Nordisk's total assets for Q4 2023 were kr314.49B, an increase of 25.78% from the previous quarter. NVO total liabilities were kr377.58B for the fiscal quarter, a 121.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.